Eloxx Pharmaceuticals Inc (ELOX)

CUSIP: 29014R301 | NYSE | Healthcare · Biotechnology | Micro Cap | 22 institutional holders

Compare Detailed Historical Funds Options 13D/13G Peers Targeting Trading Summary Profile

Beneficial Ownership — 13D / 13G

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

Holder	Shares	% of Class	Change	Event Date	vs 13F
13GNantahala Capital Management, LLC	400,000	9.9%	New 5%+ stake	Jun 30, 2026	No 13F filer matched
13GSrinivas Akkaraju with Samsara BioCapital, L.P., Samsara Opportunity Fund GP, LLC, Samsara Opportunity Fund, L.P., +1 more

Institutional Holders — Q3 2026

Sort by

Pioneer Family Office, LLC96

0.0% of portfolio$1.5K

Towne Trust Company, N.a5

0.0% of portfolio$77

Activest Wealth Management4

0.0% of portfolio$61

SBI Securities Co., Ltd.2

0.0% of portfolio$31

				Style	Turnover	Location	Filed
Pioneer Family Office, LLC	96	$1.5K	0.0%	ETF	Medium	North Miami Beach, FL	2026-10-30
Towne Trust Company, N.a	5	$77	0.0%	Core	Low	Newport News, VA	2026-10-28
Activest Wealth Management	4	$61	0.0%	ETF	Low	Aventura, FL	2026-10-15
SBI Securities Co., Ltd.	2	$31	0.0%	Agg Growth	Low	Tokyo, Mexico	2026-10-22

13GNantahala Capital Management, LLC400,000

9.9% of class · Jun 30, 2026New 5%+ stake

No 13F filer matched

13GSrinivas Akkaraju403,586

9.9% of class · Jun 10, 2026New 5%+ stake

with Samsara BioCapital, L.P., Samsara Opportunity Fund GP, LLC, Samsara Opportunity Fund, L.P., +1 more

No 13F filer matched